Skip to main content
SpringerLink
Log in

Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Abstract

Purpose

The aim of the study was to establish the prevalence and nature of potential adverse drug combinations of warfarin in a large post-mortem toxicology database. The concomitant use of warfarin and non-steroidal anti-inflammatory drugs (NSAIDs) was of interest as these drugs have been associated with internal bleeding both in clinical and post-mortem study settings. Another purpose was to obtain facts related to the questioned safety of warfarin-paracetamol and warfarin-tramadol combinations.

Methods

The post-mortem database was searched for a 1-year period. All warfarin-positive cases and cases containing interacting drugs, as defined by the SFINX interaction database (Swedish, Finnish, Interaction X-referencing), were included. For controls, all cases containing paracetamol or tramadol were also included, and for each warfarin-positive case, an age-, sex- and alcohol-matched control case was sourced. The contribution of anticoagulant use to the deaths was evaluated from the death certificates based on medico-legal autopsies.

Results

In 33% of the 328 warfarin-positive cases, at least one interacting drug was present, and paracetamol was the most abundant, accounting for 49% (n = 53). When paracetamol and warfarin were detected simultaneously, the number of fatal bleeds was 4.6 and 2.7 times higher compared to paracetamol or warfarin use alone respectively. The presence of an NSAID in combination with warfarin was rare, as only six cases were identified. A majority (66%) of the post-mortem blood samples had a warfarin concentration below 0.5 mg/l, and for the rest of the cases, the mean concentration was 0.70 mg/l.

Conclusions

This study supports the clinical evidence suggesting that warfarin-paracetamol interactions may create significant life-threatening conditions. It also accentuates the significant role post-mortem database research can have in improving drug safety.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Hirsh J, Dalen J, Anderson DR, Poller L, Bussey H, Ansell J, Deykin D (2001) Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 119:8S–21S

    Article  CAS  PubMed  Google Scholar 

  2. White RH, Zhou H, Romano P, Mungall D (1995) Changes in plasma warfarin levels and variations in steady-state prothrombin times. Clin Pharmacol Ther 58:588–593

    Article  CAS  PubMed  Google Scholar 

  3. Delaney JA, Opatrny L, Brophy JM, Suissa S (2007) Drug drug interactions between antithrombotic medications and the risk of gastrointestinal bleeding. CMAJ 177:347–351

    PubMed  Google Scholar 

  4. Shalansky S, Lynd L, Richardson K, Ingaszewski A, Kerr C (2007) Risk of warfarin-related bleeding events and supratherapeutic international normalized ratios associated with complementary and alternative medicine: a longitudinal analysis. Pharmacotherapy 27:1237–1247

    Article  CAS  PubMed  Google Scholar 

  5. Oden A, Fahlen M (2002) Oral anticoagulation and risk of death: a medical record linkage study. BMJ 325:1073–1075

    Article  PubMed  Google Scholar 

  6. Kucher N, Connolly S, Beckman JA, Cheng LH, Tsilimingras KV, Fanikos J, Goldhaber SZ (2004) International normalized ratio increase before warfarin-associated hemorrhage: brief and subtle. Arch Intern Med 164:2176–2179

    Article  PubMed  Google Scholar 

  7. Juntti-Patinen L, Neuvonen PJ (2002) Drug-related deaths in a university central hospital. Eur J Clin Pharmacol 58:479–482

    Article  CAS  PubMed  Google Scholar 

  8. Au N, Rettie AE (2008) Pharmacogenomics of 4-hydroxycoumarin anticoagulants. Drug Metab Rev 40:355–375

    Article  CAS  PubMed  Google Scholar 

  9. Holbrook AM, Pereira JA, Labiris R, McDonald H, Douketis JD, Crowther M, Wells PS (2005) Systematic overview of warfarin and its drug and food interactions. Arch Intern Med 165:1095–1106

    Article  CAS  PubMed  Google Scholar 

  10. Greenblatt DJ, von Moltke LL (2005) Interaction of warfarin with drugs, natural substances, and foods. J Clin Pharmacol 45:127–132

    Article  CAS  PubMed  Google Scholar 

  11. Gasse C, Hollowell J, Meier CR, Haefeli WE (2005) Drug interactions and risk of acute bleeding leading to hospitalisation or death in patients with chronic atrial fibrillation treated with warfarin. Thromb Haemost 94:537–543

    CAS  PubMed  Google Scholar 

  12. Ornetti P, Ciappuccini R, Tavernier C, Maillefert JF (2005) Interaction between paracetamol and oral anticoagulants. Rheumatology (Oxford) 44:1584–1585

    Article  CAS  Google Scholar 

  13. Gebauer MG, Nyfort-Hansen K, Henschke PJ, Gallus AS (2003) Warfarin and acetaminophen interaction. Pharmacotherapy 23:109–112

    Article  PubMed  Google Scholar 

  14. Andrews FJ (2002) Retroperitoneal haematoma after paracetamol increased anticoagulation. Emerg Med J 19:84–85

    Article  CAS  PubMed  Google Scholar 

  15. Parra D, Beckey NP, Stevens GR (2007) The effect of acetaminophen on the international normalized ratio in patients stabilized on warfarin therapy. Pharmacotherapy 27:675–683

    Article  CAS  PubMed  Google Scholar 

  16. Mahe I, Bertrand N, Drouet L, Bal dit Sollier C, Simoneau G, Mazoyer E, Caulin C, Bergmann JF (2006) Interaction between paracetamol and warfarin in patients: a double-blind, placebo-controlled, randomized study. Haematologica 91:1621–1627

    CAS  PubMed  Google Scholar 

  17. Mahe I, Bertrand N, Drouet L, Simoneau G, Mazoyer E, Bal dit Sollier C, Caulin C, Bergmann JF (2005) Paracetamol: a haemorrhagic risk factor in patients on warfarin. Br J Clin Pharmacol 59:371–374

    Article  CAS  PubMed  Google Scholar 

  18. Whyte IM, Buckley NA, Reith DM, Goodhew I, Seldon M, Dawson AH (2000) Acetaminophen causes an increased international normalized ratio by reducing functional factor VII. Ther Drug Monit 22:742–748

    Article  CAS  PubMed  Google Scholar 

  19. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE (1998) Acetaminophen and other risk factors for excessive warfarin anticoagulation. JAMA 279:657–662

    Article  CAS  PubMed  Google Scholar 

  20. Gadisseur AP, Van Der Meer FJ, Rosendaal FR (2003) Sustained intake of paracetamol (acetaminophen) during oral anticoagulant therapy with coumarins does not cause clinically important INR changes: a randomized double-blind clinical trial. J Thromb Haemost 1:714–717

    Article  CAS  PubMed  Google Scholar 

  21. Kwan D, Bartle WR, Walker SE (1999) The effects of acetaminophen on pharmacokinetics and pharmacodynamics of warfarin. J Clin Pharmacol 39:68–75

    Article  CAS  PubMed  Google Scholar 

  22. Thijssen HH, Soute BA, Vervoort LM, Claessens JG (2004) Paracetamol (acetaminophen) warfarin interaction: NAPQI, the toxic metabolite of paracetamol, is an inhibitor of enzymes in the vitamin K cycle. Thromb Haemost 92:797–802

    CAS  PubMed  Google Scholar 

  23. Lehmann DE (2000) Enzymatic shunting: resolving the acetaminophen-warfarin controversy. Pharmacotherapy 20:1464–1468

    Article  CAS  PubMed  Google Scholar 

  24. National Institute of Standards and Technology (NIST, USA) (2006) AMDIS software. http://chemdata.nist.gov/massspc/amdis/index.html. Accessed March 2006

  25. Duodecim (2009) Lääkeaineinteraktiot SFINX. http://www.terveysportti.fi/. Accessed 23 March 2009

  26. Wittkowsky AK, Boccuzzi SJ, Wogen J, Wygant G, Patel P, Hauch O (2004) Frequency of concurrent use of warfarin with potentially interacting drugs. Pharmacotherapy 24:1668–1674

    Article  CAS  PubMed  Google Scholar 

  27. Feldstein AC, Smith DH, Perrin N, Yang X, Simon SR, Krall M, Sittig DF, Ditmer D, Platt R, Soumerai SB (2006) Reducing warfarin medication interactions: an interrupted time series evaluation. Arch Intern Med 166:1009–1015

    Article  PubMed  Google Scholar 

  28. Snaith A, Pugh L, Simpson CR, McLay JS (2008) The potential for interaction between warfarin and coprescribed medication: a retrospective study in primary care. Am J Cardiovasc Drugs 8:207–212

    Article  CAS  PubMed  Google Scholar 

  29. Sihvo S, Klaukka T, Martikainen J, Hemminki E (2000) Frequency of daily over-the-counter drug use and potential clinically significant over-the-counter-prescription drug interactions in the Finnish adult population. Eur J Clin Pharmacol 56:495–499

    Article  CAS  PubMed  Google Scholar 

  30. Battistella M, Mamdami MM, Juurlink DN, Rabeneck L, Laupacis A (2005) Risk of upper gastrointestinal hemorrhage in warfarin users treated with nonselective NSAIDs or COX-2 inhibitors. Arch Intern Med 165:189–192

    Article  CAS  PubMed  Google Scholar 

  31. Dumo PA, Kielbasa LA (2006) Successful anticoagulation and continuation of tramadol therapy in the setting of a tramadol-warfarin interaction. Pharmacotherapy 26:1654–1657

    Article  PubMed  Google Scholar 

  32. Sabbe JR, Sims PJ, Sims MH (1998) Tramadol-warfarin interaction. Pharmacotherapy 18:871–873

    CAS  PubMed  Google Scholar 

  33. Scher ML, Huntington NH, Vitillo JA (1997) Potential interaction between tramadol and warfarin. Ann Pharmacother 31:646–647

    CAS  PubMed  Google Scholar 

  34. Hedenmalm K, Lindh JD, Sawe J, Rane A (2004) Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. Eur J Clin Pharmacol 60:369–372

    Article  CAS  PubMed  Google Scholar 

  35. Denooz R, Douamba Z, Charlier C (2008) Fatal intoxications by acenocoumarol, phenprocoumon and warfarin: method validation in blood using the total error approach. J Chromatogr B Analyt Technol Biomed Life Sci. doi:10.1016/j.jchromb.2008.11.049

    Google Scholar 

  36. Riley DA, Koves EM (1992) HPLC identification and quantitation of warfarin in postmortem blood. Can Soc Forens Sci J 25:191–199

    CAS  Google Scholar 

  37. Sun S, Wang M, Su L, Li J, Li H, Gu D (2006) Study on warfarin plasma concentration and its correlation with international normalized ratio. J Pharm Biomed Anal 42:218–222

    Article  CAS  PubMed  Google Scholar 

  38. Osselton MD, Hammond MD, Moffat AC (1980) Distribution of drugs and toxic chemicals in blood. J Forensic Sci Soc 20:187–193

    Article  CAS  PubMed  Google Scholar 

  39. Jones AW, Larsson H (2004) Distribution of diazepam and nordiazepam between plasma and whole blood and the influence of hematocrit. Ther Drug Monit 26:380–385

    Article  CAS  PubMed  Google Scholar 

  40. Schulz M, Schmoldt A (2003) Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58:447–474

    CAS  PubMed  Google Scholar 

  41. Launiainen T, Vuori E, Ojanpera I (2009) Prevalence of adverse drug combinations in a large post-mortem toxicology database. Int J Legal Med 123:109–115

    Article  PubMed  Google Scholar 

  42. Rasanen I, Kontinen I, Nokua J, Ojanperä I, Vuori E (2003) Precise gas chromatography with retention time locking in comprehensive toxicological screening for drugs in blood. J Chromatogr B 788:243–250

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Forensic Medicine, University of Helsinki, P.O. Box 40, 00014, Helsinki, Finland

    Terhi Launiainen, Antti Sajantila, Ilpo Rasanen, Erkki Vuori & Ilkka Ojanperä

Authors
  1. Terhi Launiainen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Antti Sajantila
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ilpo Rasanen
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Erkki Vuori
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ilkka Ojanperä
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Terhi Launiainen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Launiainen, T., Sajantila, A., Rasanen, I. et al. Adverse interaction of warfarin and paracetamol: evidence from a post-mortem study. Eur J Clin Pharmacol 66, 97–103 (2010). https://doi.org/10.1007/s00228-009-0727-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-009-0727-3

Keywords

Search

Navigation